These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

547 related items for PubMed ID: 28751069

  • 1. Activity-Dependent Brain-Derived Neurotrophic Factor Release Is Required for the Rapid Antidepressant Actions of Scopolamine.
    Ghosal S, Bang E, Yue W, Hare BD, Lepack AE, Girgenti MJ, Duman RS.
    Biol Psychiatry; 2018 Jan 01; 83(1):29-37. PubMed ID: 28751069
    [Abstract] [Full Text] [Related]

  • 2. BDNF release is required for the behavioral actions of ketamine.
    Lepack AE, Fuchikami M, Dwyer JM, Banasr M, Duman RS.
    Int J Neuropsychopharmacol; 2014 Oct 31; 18(1):. PubMed ID: 25539510
    [Abstract] [Full Text] [Related]

  • 3. Activity-dependent brain-derived neurotrophic factor signaling is required for the antidepressant actions of (2R,6R)-hydroxynorketamine.
    Fukumoto K, Fogaça MV, Liu RJ, Duman C, Kato T, Li XY, Duman RS.
    Proc Natl Acad Sci U S A; 2019 Jan 02; 116(1):297-302. PubMed ID: 30559184
    [Abstract] [Full Text] [Related]

  • 4. The Requirement of L-Type Voltage-Dependent Calcium Channel (L-VDCC) in the Rapid-Acting Antidepressant-Like Effects of Scopolamine in Mice.
    Yu H, Li M, Shen X, Lv D, Sun X, Wang J, Gu X, Hu J, Wang C.
    Int J Neuropsychopharmacol; 2018 Feb 01; 21(2):175-186. PubMed ID: 29020410
    [Abstract] [Full Text] [Related]

  • 5. Rapid antidepressant-like effects of muscarinic receptor antagonists require BDNF-dependent signaling in the ventrolateral periaqueductal gray.
    Kan HW, Peng WH, Wu CC, Wang DW, Lee MT, Lee YK, Chu TH, Ho YC.
    Psychopharmacology (Berl); 2022 Dec 01; 239(12):3805-3818. PubMed ID: 36221037
    [Abstract] [Full Text] [Related]

  • 6. Role of BDNF/TrkB signaling in antidepressant-like effects of a group II metabotropic glutamate receptor antagonist in animal models of depression.
    Koike H, Fukumoto K, Iijima M, Chaki S.
    Behav Brain Res; 2013 Feb 01; 238():48-52. PubMed ID: 23098797
    [Abstract] [Full Text] [Related]

  • 7. Rapid antidepressant actions of scopolamine: Role of medial prefrontal cortex and M1-subtype muscarinic acetylcholine receptors.
    Navarria A, Wohleb ES, Voleti B, Ota KT, Dutheil S, Lepack AE, Dwyer JM, Fuchikami M, Becker A, Drago F, Duman RS.
    Neurobiol Dis; 2015 Oct 01; 82():254-261. PubMed ID: 26102021
    [Abstract] [Full Text] [Related]

  • 8. BDNF release and signaling are required for the antidepressant actions of GLYX-13.
    Kato T, Fogaça MV, Deyama S, Li XY, Fukumoto K, Duman RS.
    Mol Psychiatry; 2018 Oct 01; 23(10):2007-2017. PubMed ID: 29203848
    [Abstract] [Full Text] [Related]

  • 9. Neurotrophic and Antidepressant Actions of Brain-Derived Neurotrophic Factor Require Vascular Endothelial Growth Factor.
    Deyama S, Bang E, Kato T, Li XY, Duman RS.
    Biol Psychiatry; 2019 Jul 15; 86(2):143-152. PubMed ID: 30712809
    [Abstract] [Full Text] [Related]

  • 10. Alterations in brain-derived neurotrophic factor (BDNF) and its precursor proBDNF in the brain regions of a learned helplessness rat model and the antidepressant effects of a TrkB agonist and antagonist.
    Shirayama Y, Yang C, Zhang JC, Ren Q, Yao W, Hashimoto K.
    Eur Neuropsychopharmacol; 2015 Dec 15; 25(12):2449-58. PubMed ID: 26419294
    [Abstract] [Full Text] [Related]

  • 11. The VGF-derived peptide TLQP62 produces antidepressant-like effects in mice via the BDNF/TrkB/CREB signaling pathway.
    Lin P, Wang C, Xu B, Gao S, Guo J, Zhao X, Huang H, Zhang J, Chen X, Wang Q, Zhou W.
    Pharmacol Biochem Behav; 2014 May 15; 120():140-8. PubMed ID: 24631486
    [Abstract] [Full Text] [Related]

  • 12. Scopolamine rapidly increases mammalian target of rapamycin complex 1 signaling, synaptogenesis, and antidepressant behavioral responses.
    Voleti B, Navarria A, Liu RJ, Banasr M, Li N, Terwilliger R, Sanacora G, Eid T, Aghajanian G, Duman RS.
    Biol Psychiatry; 2013 Nov 15; 74(10):742-9. PubMed ID: 23751205
    [Abstract] [Full Text] [Related]

  • 13. Antidepressant effects of TrkB ligands on depression-like behavior and dendritic changes in mice after inflammation.
    Zhang JC, Wu J, Fujita Y, Yao W, Ren Q, Yang C, Li SX, Shirayama Y, Hashimoto K.
    Int J Neuropsychopharmacol; 2014 Oct 31; 18(4):. PubMed ID: 25628381
    [Abstract] [Full Text] [Related]

  • 14. The antidepressant-like effects of biperiden may involve BDNF/TrkB signaling-mediated BICC1 expression in the hippocampus and prefrontal cortex of mice.
    Zhou D, Zhang Z, Liu L, Li C, Li M, Yu H, Cai X, Sun X, Shen X, Wang J, Geng J, Wang C, Shi Y.
    Pharmacol Biochem Behav; 2017 Jun 31; 157():47-57. PubMed ID: 28216067
    [Abstract] [Full Text] [Related]

  • 15. Intranasal Administration of Resolvin E1 Produces Antidepressant-Like Effects via BDNF/VEGF-mTORC1 Signaling in the Medial Prefrontal Cortex.
    Deyama S, Aoki S, Sugie R, Fukuda H, Shuto S, Minami M, Kaneda K.
    Neurotherapeutics; 2023 Mar 31; 20(2):484-501. PubMed ID: 36622634
    [Abstract] [Full Text] [Related]

  • 16. Vesicular glutamate transporter 1 (VGLUT1)-mediated glutamate release and membrane GluA1 activation is involved in the rapid antidepressant-like effects of scopolamine in mice.
    Yu H, Li M, Zhou D, Lv D, Liao Q, Lou Z, Shen M, Wang Z, Li M, Xiao X, Zhang Y, Wang C.
    Neuropharmacology; 2018 Mar 15; 131():209-222. PubMed ID: 29274366
    [Abstract] [Full Text] [Related]

  • 17. M1 and m2 muscarinic receptor subtypes regulate antidepressant-like effects of the rapidly acting antidepressant scopolamine.
    Witkin JM, Overshiner C, Li X, Catlow JT, Wishart GN, Schober DA, Heinz BA, Nikolayev A, Tolstikov VV, Anderson WH, Higgs RE, Kuo MS, Felder CC.
    J Pharmacol Exp Ther; 2014 Nov 15; 351(2):448-56. PubMed ID: 25187432
    [Abstract] [Full Text] [Related]

  • 18. Neuropeptide VGF C-Terminal Peptide TLQP-62 Alleviates Lipopolysaccharide-Induced Memory Deficits and Anxiety-like and Depression-like Behaviors in Mice: The Role of BDNF/TrkB Signaling.
    Li C, Li M, Yu H, Shen X, Wang J, Sun X, Wang Q, Wang C.
    ACS Chem Neurosci; 2017 Sep 20; 8(9):2005-2018. PubMed ID: 28594546
    [Abstract] [Full Text] [Related]

  • 19. Brain-derived neurotrophic factor and its receptor tropomyosin-related kinase B in the mechanism of action of antidepressant therapies.
    Kozisek ME, Middlemas D, Bylund DB.
    Pharmacol Ther; 2008 Jan 20; 117(1):30-51. PubMed ID: 17949819
    [Abstract] [Full Text] [Related]

  • 20. Regulation of glutamate transporter 1 via BDNF-TrkB signaling plays a role in the anti-apoptotic and antidepressant effects of ketamine in chronic unpredictable stress model of depression.
    Liu WX, Wang J, Xie ZM, Xu N, Zhang GF, Jia M, Zhou ZQ, Hashimoto K, Yang JJ.
    Psychopharmacology (Berl); 2016 Feb 20; 233(3):405-15. PubMed ID: 26514555
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.